Contact this trialFirst, we need to learn more about you.
Anti-diabetic drug
Metformin + Fasting for Breast Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is studying the effect of fasting and metformin on breast cancer growth. Metformin is a diabetes drug that is associated with a decreased risk of cancer. Intermittent fasting may protect cancer patients from the toxic effects of chemotherapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service